🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Sinonasal Melanoma

Axitinib and Nivolumab for the Treatment of Mucosal Melanoma NCT05384496Phase 22 sites📍 Harrison📍 New York Memorial Sloan Kettering Cancer Center · Tests: Nivolumab and/or Ipilimumab, Stereotactic Body Radiation Therapy (SBRT), axitinib Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma NCT05546827Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Surgical resection Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496Phase 1, Phase 23 sites📍 Gilbert📍 Tucson📍 Seattle University of Arizona · Tests: Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy